ProfileGDS4718 / 224978_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 78% 75% 78% 75% 67% 87% 86% 82% 69% 72% 74% 69% 83% 82% 83% 80% 72% 83% 82% 82% 75% 72% 71% 72% 73% 88% 71% 83% 74% 88% 76% 79% 74% 78% 86% 84% 81% 82% 77% 77% 75% 84% 83% 87% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.6782978
GSM549102patient 115, normal, homogenized [OPG study]7.2444775
GSM549104patient 119, normal, homogenized [OPG study]7.6965278
GSM549108patient 138, normal, homogenized [OPG study]7.2591275
GSM549119patient 077, normal, homogenized [OPG study]6.6332267
GSM549133patient 032, cancer, homogenized [OPG study]8.8122387
GSM549139patient 042, cancer, homogenized [OPG study]8.6813586
GSM549099patient 107, normal, homogenized [OPG study]7.9577382
GSM549109patient 139, normal, homogenized [OPG study]6.8052269
GSM549110patient 046, normal, homogenized [OPG study]7.0064972
GSM549114patient 063, normal, homogenized [OPG study]7.1967974
GSM549122patient 082, normal, homogenized [OPG study]6.8281369
GSM549134patient 033, cancer, homogenized [OPG study]8.2881683
GSM549136patient 036, cancer, homogenized [OPG study]8.2039482
GSM549140patient 044, cancer, homogenized [OPG study]8.3261683
GSM549111patient 047, normal, homogenized [OPG study]7.9174780
GSM549113patient 057, normal, homogenized [OPG study]7.0473372
GSM549132patient 031, cancer, homogenized [OPG study]8.1588583
GSM549137patient 038, cancer, homogenized [OPG study]8.14482
GSM549142patient 047, cancer, homogenized [OPG study]7.7700682
GSM549100patient 110, normal, homogenized [OPG study]7.2465975
GSM549107patient 135, normal, homogenized [OPG study]7.0077172
GSM549115patient 068, normal, homogenized [OPG study]6.9715771
GSM549116patient 072, normal, homogenized [OPG study]7.0399772
GSM549120patient 078, normal, homogenized [OPG study]7.1022873
GSM549131patient 030, cancer, homogenized [OPG study]9.0083588
GSM549118patient 074, normal, homogenized [OPG study]6.9829171
GSM549129patient 027, cancer, homogenized [OPG study]8.1518183
GSM549123patient 088, normal, homogenized [OPG study]7.246674
GSM549124patient 006, cancer, homogenized [OPG study]8.7682688
GSM549126patient 015, cancer, homogenized [OPG study]7.4672676
GSM549128patient 025, cancer, homogenized [OPG study]7.8421179
GSM549103patient 117, normal, homogenized [OPG study]7.1708274
GSM549117patient 073, normal, homogenized [OPG study]7.6379478
GSM549138patient 041, cancer, homogenized [OPG study]8.6732486
GSM549141patient 045, cancer, homogenized [OPG study]8.4448484
GSM549130patient 028, cancer, homogenized [OPG study]7.8966881
GSM549101patient 111, normal, homogenized [OPG study]8.0128682
GSM549105patient 128, normal, homogenized [OPG study]7.4866977
GSM549106patient 134, normal, homogenized [OPG study]7.7045177
GSM549112patient 048, normal, homogenized [OPG study]7.3103975
GSM549125patient 011, cancer, homogenized [OPG study]8.2904484
GSM549127patient 024, cancer, homogenized [OPG study]8.177983
GSM549135patient 035, cancer, homogenized [OPG study]8.7799687